Mediclinic International PLC
Mr. Danie Meintjes started serving as Chief Executive Officer, Executive Director of Mediclinic International Plc on February 15, 2016 and resigned from these positions as of July 31, 2018. He joined the group in 1985 as the Hospital Manager of Mediclinic Sandton. He became a member of Mediclinic International Limited's Executive Committee in 1995 and a director in 1996. Seconded to the company's operations in Dubai in 2006 and appointed as the Chief Executive Officer of Mediclinic Middle East in 2007, he was named Chief Executive Officer of Mediclinic International Limited in 2010. Following its combination with Al Noor Hospitals Group plc, Mr Meintjes became Chief Executive Officer of the enlarged group in February 2016. He is Member of the Clinical Performance and Sustainability Committee of the Company.
Pharmaceutics & Biopharmaceutics Drug Targeting & Drug Development Pharmaceutical Research Pharmaceutical Materials Pharmaceutical Formulations Pharmaceutical Biotechnology Pharmaceutical Nanotechnology